Population pharmacokinetics of meropenem in febrile neutropenic patients in Korea
نویسندگان
چکیده
منابع مشابه
Population pharmacokinetics of meropenem in febrile neutropenic patients in Korea.
Population pharmacokinetic parameters of meropenem in 57 febrile neutropenic patients and minimal inhibitory concentration (MIC) data for clinically isolated Pseudomonas aeruginosa and Escherichia coli were applied to estimate the time above the MIC (T>MIC) using the Monte Carlo simulation method. Mean population clearance (CL) and volume of distribution (V(d)) of meropenem were proportional to...
متن کاملSteady-state pharmacokinetics of imipenem in febrile neutropenic cancer patients.
We ascertained the pharmacokinetics of imipenem in febrile granulocytopenic cancer patients. The values observed were both different from and significantly more variable than those observed in normal volunteers. Free drug concentrations exceeded the MIC for 90% of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus strains for greater than 6 h. The MIC for 90% of Pseudomonas aeru...
متن کاملClinical Pharmacology of Meropenem in Neonates: Effects and Pharmacokinetics
Meropenem, a carbapenem antibiotic, has a broad-spectrum activity and is active against Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influencae, Moraxella catarrhalis, gram-negative enteric bacilli as Escherichia coli, Klebsiella, Enterobacter, Serratia and Pseudomonas aeruginosa. Meropenem has excellent penetration in body tissues and in cerebrospinal fluid (in the presenc...
متن کامل466Skin lesions in febrile neutropenic patients
Mucahit Yemisen; Asli Vatan; Ilker Balkan; Ayse Salihoglu; Tugrul Elverdi; Emre Eskazan; Bilgul Mete; M.Cem Ar; Seniz Ongoren; Zafer Baslar; Resat Ozaras; Nese Saltoglu; Recep Ozturk; Teoman Soysal; Fehmi Tabak; Infectious Diseases, Istanbul University, Cerrahpasa Medical School, Istanbul, Turkey; Internal Medicine, Hematology Section, Istanbul University, Cerrahpasa Medical School, Istanbul, T...
متن کاملSafety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients.
Micafungin (FK463) is a new parenteral echinocandin. A multicenter, phase I, open-label, sequential-group dose escalation study was conducted to assess the safety, tolerability, and pharmacokinetics of micafungin in neutropenic pediatric patients. A total of 77 patients stratified by age (2 to 12 and 13 to 17 years) received micafungin. Therapy was initiated at 0.5 mg/kg per day and escalated t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Antimicrobial Agents
سال: 2006
ISSN: 0924-8579
DOI: 10.1016/j.ijantimicag.2006.05.033